"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, West Texas Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 20 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Texas Cancer Center" #1 sponsor was "US Oncology Research" with 10 trials, followed by "Radiation Therapy Oncology Group" with 6 trials sponsored, "Eisai Inc." with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "Point Therapeutics" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Texas Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Sanofi" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "West Texas Cancer Center" are "Breast Cancer" (5 trials), "Prostate Cancer" (5 trials), "Metastatic Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "West Texas Cancer Center" in a lesser frequency.

Most popular intervention types in "West Texas Cancer Center" are "Drug" (33 trials), "Radiation" (11 trials), "Other" (8 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Laboratory Biomarker Analysis" (4 trials), "Paclitaxel" (4 trials), "Cetuximab" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "West Texas Cancer Center" are 22 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "West Texas Cancer Center". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in West Texas Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in West Texas Cancer Center, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".